Bristol's Belatacept Could See Approval In Second Quarter After GMP Delay
This article was originally published in The Pink Sheet Daily
Executive Summary
The kidney transplant drug Nulojix (belatacept) is finished at the plant in Puerto Rico that won't be inspection-ready until the end of the year following a August warning letter.